Treatment of Nonarteritic Anterior Ischemic Optic Neuropathy [PDF]
Nonarteritic anterior ischemic optic neuropathy (NAION) is the most common clinical presentation of acute ischemic damage to the optic nerve. Most treatments proposed for NAION are empirical and include a wide range of agents presumed to act on thrombosis, on the blood vessels, or on the disk edema itself.
Edward J, Atkins +3 more
openaire +4 more sources
Association of aberrant brain network connectivity with visual dysfunction in patients with nonarteritic anterior ischemic optic neuropathy: a pilot study. [PDF]
Background Nonarteritic anterior ischemic optic neuropathy (NAION) is often accompanied by degeneration of optic nerve axons and ganglion cell apoptosis, but the mechanism of its effects on the cerebral cortex and visual centers is not clear.
Wang H +6 more
europepmc +2 more sources
Immunoprofiling of Nonarteritic Anterior Ischemic Optic Neuropathy. [PDF]
Nonarteritic anterior ischemic optic neuropathy (NAION) is a common acute optic neuropathy in those older than 50 years. There is no blood diagnostic test or efficient treatment for NAION. We investigated the suitability of blood inflammatory proteins as biomarkers and therapeutic targets of NAION.We conducted an exploratory, cross-sectional case ...
Mesentier-Louro LA +5 more
europepmc +3 more sources
Peripapillary and macular vascular changes in unilateral nonarteritic anterior ischemic optic neuropathy: An optical coherence tomography angiography study. [PDF]
Purpose: To assess optical coherence tomography angiography (OCTA) changes in acute nonarteritic anterior ischemic optic neuropathy (NAION) eyes compared to fellow unaffected eyes and describe the longitudinal OCTA changes within the first 12 weeks of ...
Said OM, Saif AT, Owis E, Shaheen MHAEG.
europepmc +2 more sources
Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy Risk Among Patients With Diabetes.
Importance Recent studies have suggested an association between nonarteritic anterior ischemic optic neuropathy (NAION) with semaglutide usage. However, the limitations of those analyses warrant further investigation, given the frequency of use of these ...
Hsu AY +13 more
europepmc +2 more sources
Nonarteritic Anterior Ischemic Optic Neuropathy
A systematic review including data from 9 prospective cohort studies evaluated the association between all-cause mortality, cardiovascular death, and cardiovascular incidents and circulating testosterone levels in older men.
Kaur K, Margolin E.
europepmc +2 more sources
Dimitrios Brouzas, Antonios Charakidas, Ioannis Ladas, Michael ApostolopoulosDepartment of Ophthalmology, University of Athens, Athens, GreeceIntroduction: We report on three cases of visual loss due to nonarteritic anterior ischemic optic neuropathy ...
Dimitrios Brouzas +3 more
doaj +3 more sources
Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide.
Importance Anecdotal experience raised the possibility that semaglutide, a glucagon-like peptide 1 receptor agonist (GLP-1 RA) with rapidly increasing use, is associated with nonarteritic anterior ischemic optic neuropathy (NAION).
Hathaway JT +12 more
europepmc +3 more sources
Non-Arteritic Anterior Ischemic Optic Neuropathy (NA-AION): A Comprehensive Overview
Non-arteritic anterior ischemic optic neuropathy (NA-AION) represents one of the most important causes of blindness or severely impaired vision in middle-aged and elderly people.
Maria Letizia Salvetat +4 more
doaj +3 more sources
Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes. [PDF]
Nonarteritic anterior ischemic optic neuropathy (NAION) is an untreatable condition often causing severe and irreversible visual loss in the affected eye.
Grauslund J +6 more
europepmc +2 more sources

